CA Stock MarketDetailed Quotes

MDX Medx Health Corp

Watchlist
  • 0.080
  • +0.005+6.67%
15min DelayMarket Closed Apr 25 16:00 ET
21.61MMarket Cap-8.00P/E (TTM)

About Medx Health Corp Company

Medx Health Corp is engaged in the development, manufacturing, and marketing of skin-related screening tools and phototherapy devices for pain relief and tissue repair. Its two main product lines are; SIAscopy, a medical device technology that is used to scan skin for suspicious moles and lesions; and Phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide effective treatment of pain and tissue damage in the rehabilitation market. It derives key revenue from the sale of Phototherapeutic lasers. The company sells its products internationally, of which prime revenue is generated in Canada and the United States.

Company Profile

SymbolMDX
Company NameMedx Health Corp
Founded1999
MarketTSX
Fiscal Year Ends12-31
Address1495 Bonhill Road Unit 1
CityMississauga
CountryCAN
Zip CodeL5T 1M2
Phone+1 905 670-4428

Company Executives

  • Name
  • Position
  • Salary
  • Stephen Lockyer
  • Director and Acting Chief Executive Officer
  • --
  • Christopher Freeman
  • Acting Chief Financial Officer
  • --
  • Michael Druhan
  • President, Dermatological Services and Products
  • --
  • Kenneth McKay
  • Chairman of the Board
  • --
  • David J. Hennigar, B.Com,M.B.A.
  • Vice Chairman of the Board
  • --
  • Edmund Ho, B.Sc.
  • Independent Director
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More